1Andries K,Verhasselt P,Guillemont J,et al.A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science,2005,307 (5707):223-227. 被引量：1
3Ashtekar DR,Costa-Perira R,Nagrajan K,et al.In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.Antimicrob Agents Chemother,1993,37 (2):183-186. 被引量：1
4Stover CK,Warrener P,VanDevanter DR,et al.A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.Nature,2000,405 (6789):962-966. 被引量：1
4Pathak AK, Pathak V, Seitz LE, et al. Anti-mycobactefial agents 1 Thio analogues of purine [ J ]. J Med Chem,2004,47:273. 被引量：1
5Agarwal N, Srivastava P, Raghuwanshi SK, et al. Chloropyri-midines as a new class of antimicrobial agents [ J ]. Bioorg Med Chem,2002,10:869. 被引量：1
6Saito H, Tomloka H, Sato M,et al. In vitro antimycobacterial activity of newly synthesized benzoxazinorifamycins[ J ]. Antimicrob Agents Chemother , 1991,35:542. 被引量：1
7Dietze R, Teixeira L, Rocha LMC, et al. Safety and baetericldal activity of rifalazil in patients with pulmonary tuberculosis [ J ]. Antimicrob Agents Chemother, 2001,45 : 1972. 被引量：1
8Bruzzese T, Rimaroli C, Bonabello A, et al. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species[ J ]. Arzneimittelforsch ung, 2000,50 ( 1 ) : 60. 被引量：1
9Whitehead TC, Lovering AM, Cropley IM, et al. Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-reslstant tuberculosis [ J ]. Eur J Clin Microbiol Infect Dis, 1998,17 ( 11 ) :794. 被引量：1
10Bates JH. Tuberculosis chemotherapy-the need for new antituberculosis drug is urgent[ J]. Am J Respir Crit Care Med, 1995,151:942. 被引量：1
